Advertisement

Relevante Tests zur Immundiagnostik von Tumoren des Urogenitaltraktes

  • Jörg G. D. Birkmayer
Conference paper
Part of the Verhandlungsbericht der Deutschen Gesellschaft für Urologie book series (VBDGUROLOGIE, volume 31)

Zusammenfassung

Grundlage aller immunologischer Verfahren zur Diagnostik von Tumoren bildet die Existenz von tumorspezifischen Antigenen. Ihr Nachweis bei Neoplasien des Urogenitaltraktes (Herr, 1976; Faulconer et al., 1978) stellt die theoretische Basis für deren Immundiagnostik dar. Die Antwort des Immunsystems auf die Fremdantigene einer Krebszelle ist äußerst komplex und spiegelt sich in einer Vielzahl immunologischer Reaktionen wider, die mit einer Überfülle von Methoden gemessen werden können. Es drängt sich deshalb die Frage auf, welche dieser Methoden klinisch relevant sind oder werden können.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ackermann R, Okabe T, Schroeder FH (1978) Antigenic properties of a cell line from human prostate carcinoma (EB 33). Natl Cancer Inst Monogr 49:47–63.PubMedGoogle Scholar
  2. — Adolphs HD, Steffens L (1977) Evaluation of the immunocompetence of patients with transitional cell carcinoma of the bladder. Urol Res 5:29–33.PubMedCrossRefGoogle Scholar
  3. — Chaussy Ch, Hammer C, Weinfurtner F, Wieland W, Schüller J (1980) Antitumor-Antikörper in Seren von Patienten mit Nieren- und Blasenkarzinom. Verhandlungen der Deutschen Gesellschaft für Urologie 31:316–317.Google Scholar
  4. — Fahey JL, Brosman S, Dorey F (1977) Immunological responsiveness in patients with bladder cancer. Cancer Res 37:2875–2878.PubMedGoogle Scholar
  5. — Faulconer RJ, Rosato FE, Wright GL, Schellhammer P (1978) Detection and isolation of antigens associated with renal cell carcinoma (meeting abstract). Proc Am Assoc Cancer Res 19:308.Google Scholar
  6. — Guinan PD, Bhatti RA, Ablin RJ (1978) Cell-mediated anti-tumor-associated immunity in patients with genitourinary malignancy: Carcinoma of the urinary bladder (meeting abstract). Fed Proc 38:412.Google Scholar
  7. — Hausman MS, Brosman S, Snyderman R, Mickey MR, Fahey J (1975) Defective monocyte function in patients with genitourinary carcinoma. J Natl Cancer Inst 55:1047–1054.PubMedGoogle Scholar
  8. — Hellström I, Warner GA, Hellström KE, Sjögren HO (1973) Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma. Int J Cancer 11:280.PubMedCrossRefGoogle Scholar
  9. — Hellström KE, Hellström I (1979) The need to establish whether the leukocyte adherence inhibition test is a reliable assay of tumor immunity in humans. Cancer Res 39:649–650.PubMedGoogle Scholar
  10. — Herr HW (1976) Immunobiology of human bladder cancer. J Urol 115:147–149.PubMedGoogle Scholar
  11. — Hilberg RW, Balcerzak SP, Lobuglio AF (1973) A migration inhibition factor assay for tumor immunity in man. Cell Immunol 7:152–158.PubMedCrossRefGoogle Scholar
  12. — Hollinshead A, Miller H, Tanner K, Lee O, Klausia J (1979) Soluble cell membrane antigens associated with bladder cancer. Cancer Immunol Immunother 5:93–103.Google Scholar
  13. — Martinez-Pineiro JA, Muntanola P, Hidalgo L (1977) Immunological evaluation in patients with urological cancers. Eur Urol 3:159–162.PubMedGoogle Scholar
  14. O’Toole C, Stejshal V, Perlman P, Karlsson M (1974) Lymphoid cells mediating tumor-specific cytotoxicity of carcinoma of the urinary bladder. J Exp Med 139:457–466.PubMedCrossRefGoogle Scholar
  15. — Pascal RR, Jannaccone PM, Rollwagen FM, Harding TA, Bennett SJ (1976) Electron microscopy and immunfluorescence of glomerular complex deposits in cancer patients. Cancer Res 36:43–47.PubMedGoogle Scholar
  16. — Pierce GE (1978) Tumor immunity as related to the clinical course of cancer. In: Waters H (ed) The handbook of cancer immunology, Vol 3. Garland STPM, London New York, p 71–106.Google Scholar
  17. — Sigel MM (1978) The immunology of cancer of the urinary bladder. In: Waters H (ed) The handbook of cancer immunology, Vol. 3. Garland STPM, London New York, p 263–290.Google Scholar
  18. — Thatcher N, Barnard RJ, Gasiunas N, Crowther D (1977) Changes in cellular immunity following nephrectomy for localized and metastatic hypernephroma. Eur J Cancer 13:951–956.PubMedCrossRefGoogle Scholar
  19. — Tonder O, Krishnan EC, Jewell WR, Morse PS, Humphrey LJ (1976 Tumor FC receptors and tumor associated immunglobulins. Acta Pathol Microbiol Scand [C] 84:105–111Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1980

Authors and Affiliations

  • Jörg G. D. Birkmayer
    • 1
  1. 1.Institut für Zellbiologie derLudwig-Maximilians-UniversitätMünchen 2Deutschland

Personalised recommendations